Photo: Filepic/The Star
WE have come a long way with our national healthcare infrastructure since independence in 1957.
We reached another milestone at the start of this year when Malaysia became the seventh country included by a large multinational pharmaceutical company for a first in human (FIH) clinical trial, and the first within the Asia Pacific region, of a new, yet to be named drug being developed for use in rheumatology (The Star, Jan 4; online at bit.ly/3RN2zVZ).
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
